Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02794597 · ClinicalTrials.gov registry record · NA

Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)

A NA study of Contraception, sponsored by Denver Health and Hospital Authority.

Completed
Registry status
NA
Development phase
119
Enrollment target
1
Study location

NCT02794597: Completed NA study of Contraception, sponsored by Denver Health and Hospital Authority.

NCT02794597 is a NA study of Contraception that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 119 participants, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02794597, a NA study of Contraception, has completed, sponsored by Denver Health and Hospital Authority.

COMPLETED
Registry status
NA
Development phase
119 participants
Enrollment target
1
Study location

Study Summary

Recent research suggests that women with substance use disorders may be at a higher risk of unintended pregnancy. There is a paucity of interventions specifically focused on this population. Through using mixed methods, this study proposes to develop a brief peer-led intervention (based on the Health Belief Model) to prevent unintended pregnancies among women entering opioid medication-assisted treatment; to assess acceptability, feasibility and the initial efficacy of the behavioral intervention; and to conduct exploratory analyses to identify the Health Belief Model constructs that are most influential on use of long-acting reversible contraception methods. Future research would include testing the intervention in a larger scale trial and with other populations.

Primary Outcome

Assess initial efficacy (family planning/clinical visits and uptake of birth control, specifically long-acting reversible contraceptives (LARCs) of the SHINE intervention, using baseline/follow up surveys and review of medical records at three and six months. Specifically, the number of participants that were using LARCs and the number of participants who had attended family visits at each time point.

Conditions Studied

Interventions

  • BEHAVIORAL SHINE intervention group

Study Locations (1)

Colorado

  • Denver Health and Hospital Authority - Denver

Trial Details

FieldValue
Enrollment Target 119 participants
Start Date 2016-08
Est. Completion 2019-08
Phase NA

What the finished NCT02794597 record still lists

NCT02794597 is an interventional study that assigns participants to a tested intervention. The registered 119 participants enrollment target is mid-sized for trials with a published cap, below the 453-participant average among 72 other Contraception trials with a reported enrollment target (74% lower).

The record links to 1 condition, with Contraception appearing as the primary indexed condition, and to 1 intervention - of which SHINE intervention group is the first listed.

NCT02794597 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT02794597 about?

NCT02794597 is a clinical study titled "Improving Reproductive Health for Women in Opioid Medication-Assisted Treatment (OMAT)". Recent research suggests that women with substance use disorders may be at a higher risk of unintended pregnancy. There is a paucity of interventions specifically focused on this population. Through using mixed methods, this study proposes to develop a brief peer-led intervention (based on the Healt...

What is the current status of trial NCT02794597?

This trial is currently completed. It is a NA study. The enrollment target is 119 participants. The study started on 2016-08. Estimated completion is 2019-08.

What conditions does trial NCT02794597 study?

This clinical trial studies the following conditions: Contraception.

What interventions are being tested in trial NCT02794597?

The interventions under investigation include: SHINE intervention group (BEHAVIORAL).

Who is sponsoring clinical trial NCT02794597?

This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02794597 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Contraception

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT02794597's enrollment target sits among peer trials

119 41st of 72 higher than 31 of 72 other Contraception trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Contraception trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04870762 · 119 participants · Phase 2

    Customized 3D Printed Oral Stents During Head and Neck Radiotherapy

  • NCT05559853 · 119 participants

    Developing a New MRI Technique to Understand Changes in Brain Tumors After Treatment

  • NCT06564389 · 119 participants · Phase 1

    FIH Study to Evaluate the Tolerability of PF-07832837 in Healthy Adults and Patients

  • NCT06742801 · 119 participants · NA

    Onyx™ Liquid Embolic IDE Clinical Study

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT02794597, the US trial registry maintained by the National Library of Medicine. NCT02794597 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.